J B Chemicals and Pharmaceuticals Share Price

J B Chemicals and Pharmaceuticals Share Price

NSE: JBCHEPHARM
|
Pharmaceuticals
|
S Cap
₹ 2,408.90
-₹97.10 (-3.87%)
1D
Last updated 16 Jul, 2026, 15:59 IST

J B Chemicals and Pharmaceuticals Share Price Today

As of 19 Sep 2026, J B Chemicals and Pharmaceuticals share price is ₹2,408.90. The stock opened at ₹2,506.00, compared to its previous close of ₹2,506.00. During today's trading session, J B Chemicals and Pharmaceuticals share price moved in the range of ₹2,380.00 to ₹2,525.50, with an average price of ₹2,452.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,638.50 and a high of ₹2,525.50.

₹2,380.00
3.87% down today
₹2,525.50
1D LOW
1D HIGH

J B Chemicals and Pharmaceuticals Returns Calculator

Circuit
L
H
₹2,004.80
₹3,007.20
52-week
L
H
₹1,638.50
₹2,525.50

About J B Chemicals and Pharmaceuticals

J B Chemicals and Pharmaceuticals Share Price
ISIN
INE572A01036
Sector Market Cap
₹ 38,730.77 Cr

J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.

J B Chemicals and Pharmaceuticals Financial Highlights

  • Revenue: J B Chemicals and Pharmaceuticals reported revenue of ₹4,207.94 crore in FY26 vs ₹3,956.31 crore in FY25. It showed an increase of 6.36% on a yearly basis.
  • Operating Profit: J B Chemicals and Pharmaceuticals reported an operating profit of ₹952.33 crore in FY26 vs ₹887.39 crore in FY25. It showed an increase of 7.32% on a year-on-year basis.
  • Net Profit: J B Chemicals and Pharmaceuticals reported a net profit of ₹709.47 crore in FY26 vs ₹659.58 crore in FY25. It showed an increase of 7.56% on a yearly basis.

J B Chemicals and Pharmaceuticals Quarterly Result Highlights

  • J B Chemicals and Pharmaceuticals reported revenue of ₹916.21 crore in Mar 2026, compared with ₹1,083.00 crore in Dec 2025, representing a decrease of 15.40% on a quarter-on-quarter (QoQ) basis.
  • J B Chemicals and Pharmaceuticals reported an operating profit of ₹134.69 crore in Mar 2026, compared with ₹266.87 crore in Dec 2025, representing a decrease of 49.53% on a quarter-on-quarter (QoQ) basis.
  • J B Chemicals and Pharmaceuticals reported a profit of ₹101.37 crore in Mar 2026, compared with ₹197.89 crore in Dec 2025, reflecting a decrease of 48.77% on a QoQ basis.
  • The earnings per share (EPS) of J B Chemicals and Pharmaceuticals stood at ₹45.16 during Mar 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
48.80%
FII
16.33%
Other DII
2.39%
Retail and other
13.48%
Mutual funds
19.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202515.30%
Dec 202514.88%
Jan 202614.56%
Mar 202616.33%
Mkt Cap Cr
38,730.80
P/E
46.69
P/B
7.96
ROE
18.69%
D/E
0.00
ROCE
24.94%
Div. Yield
1.07%
EPS(TTM)
42.91
Turnover
0.91
EV/EBITDA
28.92
Net Margin
17.33%
Op. Margin
27.87%
ROA
16.91%
Quick Ratio
3.70
Curr. Ratio
2.22
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
J B Chemicals & outperforming all market indices
Step 1 of 5
Valuation
Overvalued
J B Chemicals & appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
J B Chemicals & earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,47,716.0036.355.2713.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,48,120.0084.8314.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,86,038.0084.7621.7325.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,13,451.0025.044.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,858.0033.023.2211.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,05,707.0096.9519.9416.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories97,828.7030.732.5711.07%0.1812.54%377.950.68%0.4138.68
Aurobindo Pharma96,890.8026.112.569.25%0.1911.76%394.820.24%0.3841.58
Lupin95,660.0017.674.3723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,793.9046.305.8711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

J B Chemicals and Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹4,147.79₹3,917.99₹3,484.18₹3,149.28
Other Income₹60.15₹38.32₹37.27₹9.94
Total Revenue₹4,207.94₹3,956.31₹3,521.45₹3,159.22
Total Expenses₹3,228.42₹3,068.92₹2,769.94₹2,603.99
Profit Before Tax₹952.34₹887.39₹751.51₹555.23
Tax₹242.86₹227.81₹198.88₹145.23
Profit After Tax₹709.47₹659.58₹552.63₹410.01
EPS - Basic₹45.16₹42.45₹35.66₹53.00
EPS - Diluted₹44.45₹41.56₹34.85₹52.34

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹952.34₹887.39₹751.51₹555.23
Income before WC changes₹1,191.46₹1,095.95₹938.73₹751.01
Change in Assets-₹211.03-₹76.24-₹143.63-₹62.27
Change in Liabilities-₹20.27₹83.42₹138.00₹32.35
Change in WC-₹231.30₹7.17-₹5.64-₹29.92
Cash flow from Operations₹703.92₹902.45₹800.61₹625.61
Cash flow from Investing-₹585.88-₹295.90-₹403.83-₹961.79
Cash flow from Financing-₹123.10-₹579.67-₹385.49₹356.54
Total Cash Flow-₹5.05₹26.88₹11.30₹20.36
Cash (Start of the year)₹115.09₹88.22₹76.93₹56.54
Cash (End of the year)₹110.18₹115.09₹88.22₹76.93

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,059.27₹2,351.04₹2,140.78₹2,025.84
Current Assets₹2,909.37₹1,922.74₹1,853.35₹1,528.03
Total Assets₹4,968.65₹4,273.78₹3,994.13₹3,553.87
Current Liabilities₹591.16₹632.34₹868.23₹554.45
Net Current Asset₹2,318.21₹1,290.40₹985.12₹973.58
Non-Current Liabilities₹218.26₹208.13₹202.57₹519.07
Equity Capital₹4,159.22₹3,433.32₹2,923.33₹2,480.35
Total Equity & Liabilities₹4,968.65₹4,273.78₹3,994.13₹3,553.87

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,889.89₹3,722.92₹3,298.64₹2,884.16
Other Income₹55.28₹34.74₹34.67₹8.65
Total Revenue₹3,945.17₹3,757.66₹3,333.32₹2,892.81
Total Expenses₹3,015.26₹2,880.56₹2,594.98₹2,365.77
Profit Before Tax₹902.73₹877.11₹738.34₹527.04
Tax₹228.63₹224.56₹194.98₹138.15
Profit After Tax₹674.10₹652.54₹543.36₹388.89
EPS - Basic₹42.91₹42.00₹35.07₹50.29
EPS - Diluted₹42.23₹41.16₹34.30₹49.69

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹902.73₹877.11₹738.34₹527.04
Income before WC changes₹1,111.93₹1,071.17₹925.60₹729.85
Change in Assets-₹204.76-₹76.58-₹140.93-₹56.66
Change in Liabilities-₹16.19₹82.28₹132.29₹44.04
Change in WC-₹220.94₹5.70-₹8.64-₹12.62
Cash flow from Operations₹644.89₹884.03₹789.03₹628.64
Cash flow from Investing-₹587.21-₹289.93-₹412.45-₹955.88
Cash flow from Financing-₹107.68-₹574.27-₹374.08₹343.41
Total Cash Flow-₹50.00₹19.84₹2.50₹16.17
Cash (Start of the year)₹76.21₹56.37₹53.88₹37.69
Cash (End of the year)₹26.36₹76.21₹56.37₹53.88

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,106.18₹2,399.24₹2,198.24₹2,071.85
Current Assets₹2,717.32₹1,778.65₹1,715.40₹1,398.30
Total Assets₹4,823.50₹4,177.90₹3,913.64₹3,470.15
Current Liabilities₹560.91₹584.44₹821.06₹508.03
Net Current Asset₹2,156.41₹1,194.22₹894.34₹890.27
Non-Current Liabilities₹224.88₹216.26₹206.32₹519.64
Equity Capital₹4,037.71₹3,377.19₹2,886.26₹2,442.48
Total Equity & Liabilities₹4,823.50₹4,177.90₹3,913.64₹3,470.15
* All values are in INR Crore
Qty
Bid
2703
2408.9
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 2703
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
60.5
Neutral
ATR (14)
59.76
Neutral
STOCH(9,6)
33.41
Neutral
STOCH RSI (14)
0
Bullish
ADX(9)
48.95
Bearish
UO(9)
59.33
Neutral
ROC(12)
4.92
Bullish
WillR(14)
-40.32
Neutral
Period
Simple value
Exponential vaue
5D
2459.6
2448.89
10D
2435.49
2423.45
20D
2344.27
2366.34
50D
2241.45
2259.72
100D
2142.03
2164.37

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
J B Chemicals and Pharmaceuticals Share Price
J B Chemicals and Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

J B Chemicals and Pharmaceuticals Share Price FAQs

J B Chemicals and Pharmaceuticals share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837